patient-centric trial Archives

decentralized clinical trial hybrid clinical trial

COVID-19 and the Changing Landscape of Clinical Trials

Featured in Applied Clinical Trials: Decentralized trials are the way of the future—yet it would be ill-advised to think of them as a one-size-fits-all solution. While the pandemic increased the industry’s acceptance of decentralized clinical trial protocols, moving to an entirely virtual model without in-person interaction is unrealistic. This sort of hybrid approach allows researchers …

COVID-19 and the Changing Landscape of Clinical Trials Read More »

Caring for Rare: Navigating a Complex Journey

Education / By Alisa Mcdonald

A rare disease diagnosis poses more questions than answers for parents learning that their child has a severe and often untreatable condition. According to the National Organization for Rare Disorders (NORD), there are over 7,000 known rare diseases, with 90% of these having no effective treatment. Obtaining a diagnosis is only the first step and …

Caring for Rare: Navigating a Complex Journey Read More »

newborn screening awareness month clinical trial

Newborn Screening Awareness Month: Creating a Federalized Screening Program

Education / By Suzanne Hamberger

September is Newborn Screening Awareness Month Newborn Screening is a modern medical practice many believe to be the most successful public health program in United States history. Since the 1960s, every infant born in America receives a heel prick within the first 48 hours of life. The resulting dried blood is then tested for a …

Newborn Screening Awareness Month: Creating a Federalized Screening Program Read More »

Advancing Clinical Trials with Patient Support

Media Coverage / By Alexis Lynch

Featured in Pharmaceutical Outsourcing: Losing a single patient during a clinical trial can mean giving up crucial data and extending trial timelines, often resulting in significant financial repercussions for trial sponsors and their research partners.

covid-19 patient safety travel recruitment retention

COVID-19 Solutions: Prioritizing Safety, Recruitment, and Retention

Education / By Suzanne Hamberger

Prioritizing Patient Safety, Recruitment, and Retention Almost two years after its initial outbreak, COVID-19 continues to cause numerous problems for sites, sponsors, and patients enrolled in clinical trials. New disease variants are creating an increase in cases, resulting in additional barriers to clinical trial participation. For patients in the rare disease space, these issues further …

COVID-19 Solutions: Prioritizing Safety, Recruitment, and Retention Read More »

patient concierge hospitality clinical trials

Podcast: A Touch of Hospitality for Clinical Trials

Media Coverage / By Alexis Lynch

Scott Gray, founder and CEO Clincierge, discusses the biggest changes in clinical trial operations, patient centricity, and shares a few stories about obstacles overcome during the coronavirus pandemic during a podcast session with Applied Clinical Trials.

Overcoming participation barriers to rare disease clinical trials

Overcoming Participation Barriers for Rare Disease Clinical Trials

Media Coverage / By Suzanne Hamberger

In the August issue of InFocus, Clincierge shares actionable ways to overcome participation barriers for rare diseases. Steps to overcoming participation barriers include coordinating access on a global scale, removing geographic barriers to participation, and leveraging patient coordinators to ensure patient comfort.

Break barriers to clinical trial participation

Reducing Barriers to Participation in Clinical Trials for Rare Disease

Media Coverage / By Alexis Lynch

Research teams who appreciate the unique needs of rare disease patients and invest in a white-glove approach on behalf of trial participants can reduce barriers to participation. For sponsors, clinical study teams, and site staff, this means easier patient recruitment at the beginning of a study and fewer dropouts throughout the duration of the trial—with …

Reducing Barriers to Participation in Clinical Trials for Rare Disease Read More »

Achieving Clinical Trial Diversity Through Actionable Steps

Media Coverage / By Suzanne Hamberger

The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and …

Achieving Clinical Trial Diversity Through Actionable Steps Read More »

Diversity in Clinical Trials: Going Beyond Why to How

Media Coverage / By Suzanne Hamberger

Diversity in Clinical Trials: Going Beyond Why to How Diversity is a hot-button issue within the global medical community. The industry continues to seek effective and sustainable solutions to create more diverse clinical trials. Our CEO, Scott Gray, joined Michael Causey, Editor-in-Chief, ACRP TV, to share his insight and practical methods for improving diversity in …

Diversity in Clinical Trials: Going Beyond Why to How Read More »

patient-centric trial

COVID-19 and the Changing Landscape of Clinical Trials

Caring for Rare: Navigating a Complex Journey

Newborn Screening Awareness Month: Creating a Federalized Screening Program

Advancing Clinical Trials with Patient Support

COVID-19 Solutions: Prioritizing Safety, Recruitment, and Retention

Podcast: A Touch of Hospitality for Clinical Trials

Overcoming Participation Barriers for Rare Disease Clinical Trials

Reducing Barriers to Participation in Clinical Trials for Rare Disease

Achieving Clinical Trial Diversity Through Actionable Steps

Diversity in Clinical Trials: Going Beyond Why to How

Copyright © 2023 Clincierge

Voice of the Patient Research